1. Home
  2. PXED vs BHVN Comparison

PXED vs BHVN Comparison

Compare PXED & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PXED

Phoenix Education Partners Inc.

N/A

Current Price

$31.78

Market Cap

1.2B

Sector

Real Estate

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.72

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
BHVN
Founded
1976
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
PXED
BHVN
Price
$31.78
$11.72
Analyst Decision
Buy
Buy
Analyst Count
7
15
Target Price
$45.00
$29.43
AVG Volume (30 Days)
142.8K
3.2M
Earning Date
01-13-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.51
N/A
Revenue
$1,007,192,000.00
N/A
Revenue This Year
$4.15
N/A
Revenue Next Year
$4.86
$1,147.70
P/E Ratio
$9.74
N/A
Revenue Growth
6.02
N/A
52 Week Low
$23.52
$7.48
52 Week High
$47.08
$44.28

Technical Indicators

Market Signals
Indicator
PXED
BHVN
Relative Strength Index (RSI) N/A 56.08
Support Level N/A $9.32
Resistance Level N/A $11.72
Average True Range (ATR) 0.00 1.03
MACD 0.00 0.04
Stochastic Oscillator 0.00 92.96

Price Performance

Historical Comparison
PXED
BHVN

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: